pindolol has been researched along with hydralazine in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (57.89) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Howson, W; Reavill, DR; Slater, RA; Swayne, GT; Taylor, EM | 1 |
| Comer, WT; Deitchman, D; Dennis, RD; Kreighbaum, WE; Matier, WL; Minielli, JL; Perhach, JL | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Boulogne, M; Honore, P; Lanciaux, B; Monnier, JC | 1 |
| Barnett, AJ; Guest, C; Kalowski, S | 1 |
| Persson, I | 2 |
| Jongsma, HW; Menssen, JJ; Mooij, PN; Nijhuis, JG | 1 |
| Boner, G; Bott-Kanner, G; Friedman, S; Merlob, P; Nissenkorn, A; Ovadia, J; Paran, E; Reisner, S; Rosenfeld, J; Zmora, E | 1 |
| Achermann, R; Groth, H; Kuhlmann, U; Siegenthaler, W; Vetter, H; Vetter, W | 1 |
| Abernethy, JD | 1 |
| Bogers, WA; Holmes, DG; Huunan-Seppala, A; Wideroe, B; Wideroe, TE | 1 |
| Seedat, YK | 1 |
| Holzberg, G; Insler, V; Mazor, M; Paran, E; Zmora, E | 1 |
| Araki, H; Gomita, Y; Kawasaki, H; Mimaki, Y; Nakatsuma, A; Okazaki, M | 1 |
2 review(s) available for pindolol and hydralazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Intracranial pressure and fetal heart rate in a hydrocephalic fetus during labor.
Topics: Adult; Drainage; Female; Heart Rate, Fetal; Humans; Hydralazine; Hydrocephalus; Intracranial Pressure; Labor, Induced; Pindolol; Pregnancy; Ultrasonography | 1992 |
9 trial(s) available for pindolol and hydralazine
| Article | Year |
|---|---|
Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Middle Aged; Patient Compliance; Pindolol | 1978 |
Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
Topics: Adult; Aged; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Pindolol; Placebos | 1975 |
Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Middle Aged; Pindolol; Placebos; Pulse | 1976 |
Treatment of hypertension during pregnancy with hydralazine monotherapy or with combined therapy with hydralazine and pindolol.
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Random Allocation | 1986 |
[Diuretics and antihypertensive agents in chronic kidney insufficiency: comparison of the effects of metolazone and furosemide].
Topics: Adult; Aged; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Hydralazine; Hypertension, Renal; Kidney Failure, Chronic; Male; Metolazone; Middle Aged; Pindolol | 1985 |
The Australian National Blood Pressure Study.
Topics: Adult; Aged; Antihypertensive Agents; Australia; Chlorothiazide; Clinical Trials as Topic; Clonidine; Ethics, Medical; Female; Humans; Hydralazine; Hypertension; Male; Mass Screening; Methyldopa; Middle Aged; Pindolol; Placebos; Propranolol | 1974 |
Endralazine, a new peripheral vasodilator: absence of effect of acetylator status on antihypertensive effect.
Topics: Acetylation; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Female; Genes; Humans; Hydralazine; Hydrazones; Hypertension; Male; Pindolol; Pyridazines | 1983 |
Guanfacine alone and in combination therapy in the treatment of moderate and severe hypertension.
Topics: Antihypertensive Agents; Benzothiadiazines; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Guanfacine; Guanidines; Humans; Hydralazine; Hypertension; Phenylacetates; Pindolol; Sodium Chloride Symporter Inhibitors | 1983 |
Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Blood Glucose; Blood Pressure; Drug Therapy, Combination; Female; Fetus; Heart Rate; Humans; Hydralazine; Hypertension; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Propranolol | 1995 |
8 other study(ies) available for pindolol and hydralazine
| Article | Year |
|---|---|
Design and synthesis of a series of combined vasodilator/beta-adrenoceptor antagonists based on 6-arylpyridazinones.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Cats; Female; Male; Pyridazines; Rats; Structure-Activity Relationship; Sympathomimetics; Vasodilator Agents | 1988 |
Antihypertensive indole derivatives of phenoxypropanolamines with beta-adrenergic receptor antagonist and vasodilating activity.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Hypertension; Indoles; Male; Propanolamines; Rats; Structure-Activity Relationship; Sympathomimetics; Vasodilator Agents | 1980 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
[Value of hydralazine-beta blockader association in hypertension of pregnancy].
Topics: Adrenergic beta-Antagonists; Adult; Drug Therapy, Combination; Female; Fetus; Humans; Hydralazine; Hypertension; Oxprenolol; Pindolol; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Propranolol | 1978 |
Long-term treatment with angiotensin converting enzyme inhibitor restores reduced calcitonin gene-related peptide-containing vasodilator nerve function in mesenteric artery of spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcitonin Gene-Related Peptide; Captopril; Electric Stimulation; Hydralazine; Hypertension; In Vitro Techniques; Male; Mesenteric Arteries; Pindolol; Rats; Rats, Inbred SHR; Thiazepines; Time Factors; Vascular Resistance; Vasodilation | 1999 |